Non-Dilutive Funding Mega-Panel: The Relationship Between Industry and Non-Dilutive Sources
February 23, 2016/by Ayal Ronen11th Annual Non-Dilutive Funding Summit Keynote Address
February 23, 2016/by Ayal RonenNIAID Presentation – Infectious Disease Product Enabling Opportunities with NIAID
February 23, 2016/by Ayal RonenNIBIB Presentation – Funding Opportunities for Medical Device Development
February 23, 2016/by Ayal RonenNational MS Society Presentation – Accelerating Translational R&D for Multiple Sclerosis
February 23, 2016/by Ayal RonenMJFF Presentation – How Venture Philanthropy De-Risks Research in Parkinson’s Disease
February 23, 2016/by Ayal RonenLSN Presentation – Fundraising Best Practices
February 23, 2016/by Ayal RonenCureDuchenne Presentation – The Critical Role of Venture Philanthropy in Developing DMD Therapeutics
February 22, 2016/by Ayal Ronen
2nd Annual Biotech and Money London 2016, 2-3 February
January 18, 2016/by Ayal Ronen
BioTrinity 2016 – Europe’s Leading Investment and Biopartnering Conference, 25 – 27 April 2016
November 30, 2015/by Ayal Ronen
Redefining Early Stage Investments (RESI) Conference – San Francisco, January 12, 2016
October 15, 2015/by Ayal Ronen
11th Annual Non-Dilutive Funding Summit
September 2, 2015/by Ayal RonenSearch
Recent Posts
RESI San Diego, June 22, 2026 in San DiegoMay 26, 2026 - 9:29 am
CDMRPs Announced 2026May 7, 2026 - 9:35 am
BIO Partnering for Oncology, May 28-31, 2026, Chicago, USAApril 15, 2026 - 8:22 am
LSX Nordic Congress, May 19-20, 2026, Copenhagen, DenmarkApril 15, 2026 - 8:15 am
AngloNordic, April 23, 2026, LondonMarch 19, 2026 - 12:29 pm
